Navigation Links
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
Date:5/22/2009

ANNAPOLIS, Md., May 22 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company has submitted its comprehensive regulatory strategy to the U.S. Food and Drug Administration (FDA) outlining the non-clinical and clinical development plans for licensure of SparVax(TM), a next generation recombinant protective antigen anthrax vaccine.

The FDA submission is in response to recent amendments issued by the Department of Health and Human Services (HHS) on April 15th and 22nd, 2009, to solicitation number RFP BARDA 08-15, outlining a requirement to develop and procure 25 million doses of a next generation rPA anthrax vaccine for the country's civilian biomedical stockpile.

In September 2008, PharmAthene received notification from HHS that its proposal for SparVax(TM) had been deemed technically acceptable and within the competitive range for procurement consideration. Since that time, PharmAthene has been engaged in negotiations with HHS under the proposals process.

David P. Wright, President and Chief Executive Officer of PharmAthene, noted, "We are pleased to have met our stated goal of submitting our regulatory plan to FDA by May 21st, well ahead of the June 15th submission deadline. We feel we have presented a comprehensive and credible path for the ultimate licensure of SparVax(TM). We continue to maintain an ongoing dialogue with FDA, and anticipate an expeditious review of our development plan. In the meantime, activities under the SparVax(TM) program continue to advance uninterrupted under a development contract for SparVax(TM) originally awarded by the National Institute of Allergy and Infectious Disease (NIAID) and transferred to the Biomedical Advanced Research and Deve
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
2. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
5. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
6. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
7. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
8. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
9. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
10. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
11. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Luoxis Diagnostics, Inc. , a ... MKT: AMPE), today announced an upcoming presentation at ... American Academy of Surgical Trauma (AAST) and Clinical ... Philadelphia, Pennsylvania that will be held ... from a recently completed five-year prospective clinical trial ...
(Date:8/19/2014)... 19, 2014 According to a ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation ... and Forecast, 2014 - 2020", the global surgical navigation ... 2013 and is expected to grow at a CAGR ... estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... 2014 Elbit Imaging Ltd. ("EI" ... announced today that Elbit Medical Technologies Ltd. ("Elbit Medical") ... it holds approximately 86% of the voting power, announced ... which Elbit Medical holds approximately 30.8% of the voting ... Cell,s shareholders (including Elbit Medical), signed Option and Investment ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 3
(Date:8/19/2014)... (PRWEB) August 20, 2014 The elegant ... people can upgrade their houses in an environmentally conscious ... made of solid materials and have an aluminum oxide ... them well suited for high-traffic areas. , Recently, the ... strand woven bamboo floorings . These fresh items are ...
(Date:8/19/2014)... 20, 2014 Midtown Dentistry in Houston, Texas, ... office. All patients with cavities, or with old fillings ... fillings that can safely repair and restore teeth. , From ... latest materials, all of which are completely amalgam free. Even ... use by the FDA for adults and children over the ...
(Date:8/19/2014)... 2014 What gives skin an edge and ... skin, replenish and nourish it while lightly exfoliating? The ... after client raves about how their skin feels and looks ... Sublime Beauty®. "The ingredients are very rich and spa-quality." ... smooth it over cleansed skin of the face and neck, ...
(Date:8/19/2014)... in this week,s JAMA highlights the importance ... considering how to treat patients. Written by Robert Vinci, ... chair of pediatrics at Boston University School of Medicine ... the editorial examines results of a study published in ... of how doctors can often over-emphasize certain types of ...
(Date:8/19/2014)... a popular supplier of fashionable wedding, bridesmaid, evening, prom, ... a discount of up to 67% on all ... outfits are available in different necklines; ladies can choose ... are over 400 cheap white prom dresses listed in ... valid until August 29, 2014. The discounted products feature ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2
... Clinton has once again lent a helping hand to HIV/ ... government and drug giant Merck over pricey anti-retroviral drugs, ... a deal with two Indian pharmaceutical companies Cipla and Matrix, ... second-line AVR drugs and a next generation one-pill-a-day drug. ...
... the potency of platinum-based cancer drugs when administered together to ... with tumors, scientists from Dana-Farber Cancer Institute report. ... halted or shrank mouse tumors as much as three times ... to the article in the May issue of Cancer Cell. ...
... be one way of treating diseases such as epilepsy ... seem to have pitched upon a protein that could do ... amount of information transmitted to cells. ,And so ... the key to tackling diseases such as epilepsy and schizophrenia, ...
... clinical study that relates the collapse of the trade center ... of dust and pollutants during the rescue operation. The rescuers ... which showed up a year after the catastrophe. ... Einstein College of Medicine found that 13 firefighters and emergency ...
... fruit, vitamins and minerals, and ate less fat , salt and ... these , stood to gain not in terms of weight ... the effects of 100% juice consumption on weight, has dispelled any ... health survey conducted from 1999 to 2002 and studying about 3,600 ...
... have more sleep problems than children from middle class ... school, according to research. ,The study compared ... who were African American and Hispanic, to the sleeping ... children were 4 to 10 years old. Parents were ...
Cached Medicine News:Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 3Health News:British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia 2
... The RCAI Hip Abduction Orthosis provides ... due to involved post-op hip revision, for ... dysphasia or to stabilize spastic, tight adductors ... ,The Hip Abduction Orthosis features flexion/extension ...
Modular hip abduction system designed to provide superior fit, adjustability and functionality for optimum patient stability, comfort and compliance...
... A Pavlik-type harness with greatly improved ... of congenital hip dysplasia. Color-coded straps, ... antislip foot pieces.,Color-coded anterior straps help ... be made while the child lies ...
... in walker design in years. A real step forward! ... surfaces of the foot rest on adaptive areas of ... strike. The footbed in the sole conforms to the ... stability. , ,No leg length discrepancy; Heel height ...
Medicine Products: